Mei Mei Tian
Technik-/Wissenschafts-/F&E-Leiter bei BIOASIS TECHNOLOGIES INC.
Ursprung des Netzwerks ersten Grades von Mei Mei Tian
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 28 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mei Mei Tian
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| APPLIED DNA SCIENCES, INC. | Biotechnology | Chairman | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
DNA Sciences, Inc.
 DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Medical Specialties | Chairman | |
| GOLDEN GOLIATH RESOURCES LTD. | Precious Metals | Director/Board Member | |
| DIGICANN VENTURES INC. | Agricultural Commodities/Milling | Director of Finance/CFO | |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| Drexel University | College/University | Graduate Degree | |
Fasken Martineau DuMoulin LLP
 Fasken Martineau DuMoulin LLP Miscellaneous Commercial ServicesCommercial Services Fasken Martineau DuMoulin LLP operates as law firm. It provides legal services to construction, financial, insurance, life sciences, corporate, and commercial industry. It offers Labour employment and human rights, litigation and dispute resolution, and privacy and cybersecurity risk management. The company was founded in 1863 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree | |
| McGill University | College/University | Undergraduate Degree | |
One Person Health, Inc.
 One Person Health, Inc. Pharmaceuticals: MajorHealth Technology Part of NeutriSci International, Inc., One Person Health, Inc. develops dietary supplements. The company is based in Vancouver, Canada. The CEO of the Canadian company is Robin Bruce Hutchison. One Person Health was acquired by Disani Capital Corp. on February 20, 2004. | Pharmaceuticals: Major | Chief Executive Officer | |
| ROCKETINFO INC. | Computer Communications | Chairman | |
| Clark University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Undergraduate Degree | |
| PYC THERAPEUTICS LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Princeton University | College/University | Doctorate Degree | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Doctorate Degree | |
eCharge Corp.
 eCharge Corp. Miscellaneous Commercial ServicesCommercial Services eCharge Corp. provides secure online payment services. The American company was founded by Robin Bruce Hutchison and George Fleming. The CEO is Truett Tate. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| University of Victoria | College/University | Corporate Officer/Principal Undergraduate Degree | |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Law Society of British Columbia
 Law Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Law Society of British Columbia provides legal services. The firm protects the public interest in the administration of justice by setting and enforcing standards of professional conduct for lawyers. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Purdue Pharma (Canada)
 Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Purdue Pharma (Canada) manufactures and markets pharmaceutical products. It products for the treatment of pain, respiratory disease, gastrointestinal disorders, and infection control. The firm include laxatives, bronchodilators, antiseptics, and analgesics. Purdue Pharma is headquartered in Pickering, Canada | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
Biovail Laboratories International SRL
 Biovail Laboratories International SRL Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Biovail Laboratories International SRL develops, manufactures, and sells pharmaceutical products. The company is based in Saint Michael, Barbados. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| UMass Chan Medical School | College/University | Doctorate Degree Doctorate Degree | |
| Sni Corp. | President | ||
| Everex Canada, Inc. | Sales & Marketing | ||
| Vivox International, Inc. | Corporate Officer/Principal | ||
| NEVIS BRANDS INC. | Biotechnology | Director/Board Member Chairman Chief Executive Officer Chairman Director/Board Member Director of Finance/CFO | |
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Neuron23, Inc.
 Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Neuron23, Inc. is a clinical-stage biotechnology company based in an undisclosed location. The American company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The company was founded by Adam Knight and Nancy E. Stagliano has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| Rare Disease & Oncology Consulting LLC | President | ||
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Electra Therapeutics, Inc. is a clinical stage biotechnology company that develops therapies for the treatment of immunological diseases and cancer. The company is based in San Francisco, CA. The company's lead product candidate, ela026, is a monoclonal antibody that targets sirp on the cell surface of and t cells, and precisely depletes pathological immune cells. Electra currently has one program in clinical development and additional preclinical programs. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
| TURNIUM TECHNOLOGY GROUP INC. | Packaged Software | Director/Board Member Chief Executive Officer Director of Finance/CFO Director/Board Member | |
CannÖgen International, Inc.
 CannÖgen International, Inc. Pharmaceuticals: OtherHealth Technology CannÖgen International, Inc. engages in the development, production, marketing, and sale of science-based health products to address a broad spectrum of physical conditions. Its product lines are health composition products, pH beverage products, medical food compositions, and pet health products. The company was founded on March 30, 2021 and is headquartered in White Rock, Canada. | Pharmaceuticals: Other | Director/Board Member Chairman Director of Finance/CFO Director/Board Member |
Statistik
International
| Kanada | 26 |
| Vereinigte Staaten | 22 |
| Vereinigtes Königreich | 2 |
| Australien | 2 |
| Barbados | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 4 |
| Non-Energy Minerals | 2 |
Operativ
| Director/Board Member | 132 |
| Corporate Officer/Principal | 52 |
| Director of Finance/CFO | 35 |
| Chairman | 34 |
| Chief Executive Officer | 34 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Wurzer | 31 |
| Karoly Nikolich | 30 |
| Ronald Erickson | 27 |
| Christopher Lowe | 25 |
| Mario David Saltarelli | 17 |
| Robin Hutchison | 17 |
| May Orfali | 15 |
| H. Christian Fibiger | 15 |
| Nancy E. Stagliano | 15 |
| Gregory Gubitz | 12 |
| Deborah Rathjen | 12 |
| Dave Jenkins | 11 |
| Terry Pearson | 10 |
| Christine Antalik | 9 |
| Mahalakshmi Radhakrishnan | 9 |
- Börse
- Insiders
- Mei Mei Tian
- Unternehmensverbindungen
